The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient.
about
Active vaccination to prevent de novo hepatitis B virus infection in liver transplantationAntibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donorsEvidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation.Prevention of de novo HBV infection by the presence of anti-HBs in transplanted patients receiving core antibody-positive livers.Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infectionsLong-term efficacy of nucleoside monotherapy in preventing HBV infection in HBsAg-negative recipients of anti-HBc-positive donor livers.A concise update on the status of liver transplantation for hepatitis B virus: the challenges in 2002.Management of occult hepatitis B virus infection: an update for the clinician.Prophylaxis against de novo hepatitis B for liver transplantation utilizing hep B core (+) donors: does hepatitis B immunoglobulin provide a survival advantage?Use of hepatitis B core antibody-positive donors for liver transplantation.Current use of hepatitis B immune globulin for prevention of de novo hepatitis B in recipients receiving anti-HBc-positive livers.Adult Living Donor Liver Transplantation Using Hepatitis B Core Antibody-Positive Grafts in Korea, a Hepatitis B-endemic Region.Kinetics of phytohemaglutinin-induced IFN-gamma and TNF-alpha expression in peripheral blood mononuclear cells from patients with chronic hepatitis B after liver transplantationIntravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation.Treatment of hepatitis B and C after liver transplantation. Part 1, hepatitis B.Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis.Active Immunization for Prevention of De Novo HBV infection after Adult Living Donor Liver Transplantation with HBc(+) Graft.De novo hepatitis B virus infection developing after liver transplantation using a graft positive for hepatitis B core antibodySevere clinical course of de novo hepatitis B infection after liver transplantation.Natural history of patients with recurrent chronic hepatitis C virus and occult hepatitis B co-infection after liver transplantation.Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.Transmission of hepatitis B infection from hepatitis B core antibody--positive livers: background and prevention.Safe use of livers from donors with positive hepatitis B core antibody.Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients.Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.Case report of lamivudine-resistant hepatitis B virus infection post liver transplantation from a hepatitis B core antibody donor.
P2860
Q26780244-D0372089-39BE-4A06-A534-831BDA7C395DQ28344359-29D1D2B2-E7E4-4E59-8A79-3CD18A527490Q31921641-48008D14-F4B9-41C8-BD73-4D23039E98EBQ33867301-5FB65EF3-C786-4253-9FE4-09CB5423E5EDQ33891744-79C734FB-4538-4395-933B-842C43B1DFF4Q34365421-15AAB47D-6B13-4DF7-856A-133D795E6838Q34499694-EEF894BA-9C17-44E4-ACEB-F9414F105515Q34757408-CC6F93A5-EB60-4F92-8E94-F575D65F6936Q34917705-FE28D061-3F37-4D1A-AC2F-9931951A44F7Q34936283-B4A01341-091B-4E02-9AE1-74755216571DQ34959703-83049827-E290-4E15-907F-801798B2D3D3Q35195474-3B3B651E-63BD-410C-BD00-D1C9EA1E5575Q35435517-BFBFE278-6E73-49E6-A1F7-12C6142C5E18Q35715908-1BA45DC5-5CCA-48C3-A162-CDC368FE9560Q36028324-29687C11-0423-4BA9-A71A-74F1ACBC092FQ37842669-BCFE6753-DD4D-428C-82F9-AF5841698413Q40129850-780EBFD1-73C2-4956-842C-E4781AB2979EQ40543082-BA079C67-A3BA-429E-BFBA-08EA6C65DEB2Q42993325-4DCFEAD1-F0FE-44FB-9F25-BB828D36E7DDQ43001140-1F143EE4-EFCD-448C-8FB0-08F0D3EA526DQ43666871-C219D617-3C25-467A-AEB8-6F05035E1A8FQ43666875-DB2CA000-670A-463B-A495-4E449C9A540CQ44011089-83F39C62-1F8F-4D4A-8F75-153001B8A00AQ44165111-2B7B7CA8-BB00-4DC1-A1E6-B7E76E148F9DQ45408268-45863AB7-9B77-456F-9B61-E8FF422B40EBQ45414817-1C9D5CDE-7AD9-4EDF-B67E-7107F5C0D2A4Q45417753-59207ABE-BD6F-40A4-BAAA-4995E0D9BCE6
P2860
The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
The clinical course of transpl ...... he liver transplant recipient.
@en
type
label
The clinical course of transpl ...... he liver transplant recipient.
@en
prefLabel
The clinical course of transpl ...... he liver transplant recipient.
@en
P2093
P356
P1476
The clinical course of transpl ...... he liver transplant recipient.
@en
P2093
P304
P356
10.1002/LT.500030202
P577
1997-03-01T00:00:00Z